Om Power Transmission Limited Gears Up for ₹ 150 Crore IPO; Subscription Opens April 9

Chetan Bharatkumar Modi, CA Yogesh Jain, Kalpesh Dhanjibhai Patel, Kanubhai Patel, Vasantkumar Narayanbhai Patel and Hardikkumar Jitendrabhai Patel at Om Poer Transmission Press Conference


MUMBAI – Om Power Transmission Limited, a Gujarat-based specialist in high-voltage power infrastructure, is set to enter the primary market with its Initial Public Offering (IPO) on Thursday, April 09, 2026. The company has established a price band of ₹ 166 to ₹ 175 per equity share, aiming to raise approximately ₹ 15,006.25 lakhs at the upper end of the price spectrum.

Offer Structure and Timeline
The public issue consists of a fresh issue of up to 75,75,000 equity shares and an offer for sale (OFS) of up to 10,00,000 equity shares by existing shareholders.
Investors can bid for a minimum of 85 equity shares and in multiples thereof. The three-day subscription window will close on Monday, April 13, 2026, while the anchor investor bidding is scheduled for April 08. The shares are proposed to be listed on both the National Stock Exchange (NSE) and the BSE Limited.
A Decade of Infrastructure Excellence
Founded in 2011, Om Power Transmission has carved a niche in the Engineering, Procurement, and Construction (EPC) segment. The company focuses on high-voltage (HV) and extra-high voltage (EHV) transmission lines, substations, and underground cabling.
To date, the firm has commissioned over 1,000 circuit kilometers (CKM) of transmission lines and 11 substations. Its expertise spans the full EPC value chain—from design and engineering to commissioning and long-term operation and maintenance (O&M) services.
Financial Performance: A Growth Story
The company’s financial trajectory has seen a sharp upward curve. Between Fiscal 2023 and Fiscal 2025, Om Power’s revenue from operations surged from ₹ 12,023.63 lakhs to ₹ 27,943.51 lakhs, representing a CAGR of 52.45%. Even more impressive is the bottom-line growth; profit for the year grew at a CAGR of 88.17% over the same period.
For the nine-month period ending December 31, 2025, the company reported a robust revenue of ₹ 27,454.28 lakhs and a profit after tax of ₹ 2,336.80 lakhs, signaling sustained momentum heading into the IPO.
Strategic Roadmap
The net proceeds from the fresh issue are earmarked for critical growth drivers:
  • Capital Expenditure: Purchasing advanced machinery and equipment to enhance execution capacity.
  • Debt Management: Pre-payment or repayment of certain outstanding borrowings to strengthen the balance sheet.
  • Working Capital: Supporting the long-term operational needs of increasingly complex projects.
"The IPO is expected to support our next phase of growth by strengthening operational capabilities and supporting participation in larger projects," said Kalpesh Dhanjibhai Patel, Chairman and Executive Director.
Market Participation
The offer is structured to cater to diverse investor classes:
  • Qualified Institutional Buyers (QIB): Up to 42,87,175 shares.
  • Non-Institutional Investors (NII): At least 12,86,475 shares.
  • Retail Individual Investors (RII): At least 30,01,350 shares.
Beeline Capital Advisors Private Limited is acting as the Book Running Lead Manager, with MUFG Intime India Private Limited serving as the Registrar to the issue.
- Paresh B. Mehta

Autism Awareness: Dr Ketan Patel Homeopathic Physician Highlights Diet & Exercise as Key Recovery Tools

Autism treatment in Homeopathy

On this World Autism Awareness Day, Dr. Ketan Patel of Specialty Homeopathy stated that 80% of autism cases can be managed through diet and exercise alone. He noted that the remaining 20% may require medicinal support alongside lifestyle changes due to metabolic or genetic factors.

Gujarat doctors earmark Rs. 5 lakh for needy children with autism

Homeopathy has proven to be very effective in treating in such genetic, metabolic & mitochondrial autism (Syndromic AUTISM). Genetic effects can be largely eliminated or controlled through homeopathic medicines.

Dr Ketan Patel said that the effects of genes affecting sodium channel, potassium channel, aqua channel, epileptic, Encephalopathy, intellectual and other protein disruption can be eliminated up to 90 percent with homeopathic medicines along with diet and exercise. The research of these experts has found that only 10 percent of genes cannot be improved.

Dr Ketan Patel further said that “The protocols for autism treatment of Western countries do not show the effect of treatment in a certain time. There is a shortage of doctors trained to treat autism in India. Therefore, it is necessary for us to improve the protocols of Western countries and formulate our own new protocols. Indian doctors are far ahead in the treatment of autism, compared to Western countries. Therefore, it is necessary for us to implement a new protocol with diet, exercise and individual treatment plan in the treatment of autism.”


Cinematic Brilliance that defines ‘Dhurandhar – The Revenge’

Dr Jayesh Sheth said that autism is a type of disease in which children are not mentally retarded, but due to some obstruction or disturbance in the wiring of neurons in their brain, their ability to speak and think is affected. Such a gene problem is found in 50 percent of autism cases. The earlier such children are diagnosed, the more effective the treatment and guidance is.

Dr Patel and Dr Sheth further said that currently, doctors are providing up to Rs. 5,00,000 annually for the treatment, genetic testing and related therapy of more than 100 needy children suffering from autism. In the coming time, doctors from all branches like Allopathic, Homeopathic, Ayurvedic, who are doing treatment and research in the field of autism in Gujarat, are committed to jointly work with the therapists and bring about rapid treatment and improvement.

1 in every 36 children born worldwide is affected by autism. This figure is considered extremely alarming, as the number of children suffering from autism is higher than the percentage of children suffering from life-threatening diseases such as cancer, diabetes and HIV worldwide.

What is autism?

It is a disease affecting the neurological, endocrinal, and gastrointestinal systems, diagnosed in children between the ages of 18 and 24 months and its symptoms are as follows.

- The child does not speak on time or does not speak at all cannot use sentences after speaking a few words.

- Does not make eye contact with family members such as mother, father, brother, sister.

- Does not play with children of the same age group when they are playing and prefers to go away and play alone.

- Laughs and cries for no reason.

- Plays with a toy, object or piece of clothing for a long time, sleeps with it.

- Wiggles fingers, jumps, keeps moving around in one place.

- Holds hands over ears in fear of the sound of mixers, vacuum cleaners, firecrackers.

- Throws things and screams.

- Hurts body with teeth, hits head against wall.

It is advisable that if two or more of the above symptoms are observed in a child take your child to a doctor to get diagnosed with autism and get proper treatment. The earlier your child is diagnosed with autism or a similar condition, the greater the child's chances of recovering from these symptoms.

- Scientists, doctors, universities, pharmaceutical and diagnostic companies around the world are working to diagnose autism more quickly.

In order to make people aware of this disease, the World Health Organization (WHO) has declared April 2 as World Autism Awareness Day every year and the entire month of April as Autism Awareness Month to spread awareness and information about autism. During this month, famous places around the world are decorated with blue lights. Such as Sydney Opera - Australia, Burj Khalifa - Dubai, Leaning Tower - Italy, London Bridge - UK, Pyramids of Giza - Egypt, Eiffel Tower - France (Paris) are decorated with blue lights.

Diagnosis of autism

This disease, which is seen in children from the age of 18 months to 30 months, cannot be detected by any single test or other medical report such as CT SCAN, MRI SCAN, PET SCAN or EEG so apart from the above report the diagnosis can be made in the following two stages.

In the first stage, to know whether the physical and mental development of the children is happening according to their age or not, the child's learning ability, his way of speaking, words and sentences along with his facial expressions are studied and recorded and the development rate of the children (Physical & Mental Development) is kept in mind at a certain time interval such as 12 months, 18 months or 24 months i.e. at the age of 2 years. In this above study, the diagnosis is made on the basis of the answers of scientifically prepared questionnaires to the child's parents, his doctors and the child's caregivers.

The second stage is diagnosed by doctors who specialize in this disease such as a Developmental Paediatrician, Child Neurologist, Child Psychiatrist/Psychologist (specialist in child neurology and behavioural disorders), and DAN (Defeat Autism Now) doctors.

Causes of autism spectrum disorder

Doctors and scientists around the world are trying to find out the causes of this disease but have not been able to come up with a specific cause. However based on the medical history records of old cases/new cases and the similarities and differences in them, they have come to the following conclusions.

- Chronic infection in the mother's body that affects the mental development of the child during pregnancy, such as Torch Infection.

- Hormonal imbalance due to the endocrine gland in the mother, thyroid deficiency.

- Pollution in the atmosphere, pollution in drinking water

Genetic disorder

- Tuberculosis disease in family members

- Epilepsy & Seizure Disorder

- Serotonin and neurotransmitter related disease

Many children develop autism after receiving the MMR vaccine, and doctors around the world have differing opinions on the matter. According to the CDC USA (CDC – Centre for Disease Control & Prevention), 1 in 31 children born worldwide are affected by autism, and this figure is considered alarming, as it is more than the combined incidence of cancer, diabetes, and HIV.

Treatment

Both Doctors have 35 Years of experience: Dr Ketan Patel is in Treatment Part And Dr Jayesh Sheth In Genetic Metabolic & Mitochondrial Diagnostic Part

DR KETAN PATEL +91989800535454   https://specialityhomeopathy.com

DR JAYESH SHETH +91 9426001227   https://geneticcentre.org